the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

Clinical trial NCT06378840 · UNKNOWN

Trial details

NCT number: NCT06378840
Sponsor: RenJi Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Locally Advanced Cervical Carcinoma Concurrent Chemoradiotherapy Immunotherapy

Start date: 2022-01-01
Primary completion: 2024-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.